Lithium Orotate as a Novel Therapeutic Avenue for Alzheimer’s Disease: Insights from the Latest Nature Study

Highlights

• Groundbreaking Nature study reveals brain lithium deficiency is linked to Alzheimer’s disease (AD) onset.
• Lithium orotate supplementation reverses memory loss and brain pathology in AD mouse models, unlike traditional lithium carbonate.
• Lithium orotate is less likely to be sequestered by amyloid plaques and shows no observed toxicity in long-term animal studies.
• Potential implications for AD treatment and broader neuropsychiatric applications, pending human clinical trials.

Study Background and Disease Burden